Market Overview

According to fortune business insights, the global medical devices market is witnessing significant growth, driven by increasing healthcare expenditure, rising prevalence of chronic diseases, technological advancements, and growing demand for advanced diagnostic and treatment solutions. According to Fortune Business Insights, the global medical devices market size was valued at USD 572.31 billion in 2025. The market is projected to grow from USD 604.99 billion in 2026 to USD 1,032.66 billion by 2034, exhibiting a CAGR of 6.90% during the forecast period (2026–2034). North America dominated the global market, accounting for a 38.10% share in 2025.

The increasing prevalence of chronic conditions, including diabetes, cardiovascular diseases, cancer, and orthopedic disorders, is contributing to the growing demand for medical equipment and devices. Additionally, rising patient admissions and an increasing number of diagnostic and surgical procedures are supporting market expansion. According to the National Center for Biotechnology Information (NCBI), approximately 422 million people worldwide were living with diabetes, highlighting the growing need for continuous monitoring, diagnostic, and treatment devices.

Furthermore, growing research and development investments by leading manufacturers are encouraging the introduction of innovative medical technologies, improving treatment efficiency and patient outcomes.

Major Players Profiled

• Medtronic (Ireland)
• Johnson & Johnson Services, Inc. (U.S.)
• Koninklijke Philips N.V. (Netherlands)
• F. Hoffmann-La Roche Ltd. (Switzerland)
• Boston Scientific Corporation (U.S.)
• Fresenius Medical Care AG (Germany)
• GE Healthcare (U.S.)
• Siemens Healthineers AG (Germany)
• Stryker (U.S.)
• Abbott (U.S.)
• BD (U.S.)
• Cardinal Health (U.S.)

Market Segmentation

By Type: The market is segmented into orthopedic devices, cardiovascular devices, diagnostic imaging devices, in-vitro diagnostics (IVD), minimally invasive surgery devices, wound management, diabetes care devices, ophthalmic devices, dental devices, nephrology devices, general surgery, and others. The in-vitro diagnostics segment dominated the market, accounting for a 13.53% share in 2026, supported by increasing diagnostic testing and the rising prevalence of infectious diseases.

By End-User: The market is categorized into hospitals and ambulatory surgery centers (ASCs), clinics, and others. Hospitals and ASCs dominated the market with a 48.97% share in 2026, driven by increasing patient admissions and demand for advanced diagnostic and surgical equipment.